Peter Abbink, Ph.D.

Peter  received his medical laboratory degree from ROC Leiden, The Netherlands, and his B.A.S. from the University of Applied Sciences in Leiden, The Netherlands. Peter’s areas of interest are molecular biology, virology and nanotechnology. His thesis work at the University of Leiden involved identification of mutations in the human DNA mismatch repair system leading to hereditary non-polyposis colorectal cancer. Additionally, thesis work at Crucell Holland B.V. involved construction and evaluation of novel adenoviral vaccine vectors. Peter joined Dr. Dan Barouch’s lab in 2004 and has been manager of the Virology group since 2009. He leads the design, construction and production of novel adenoviral vaccine vectors and AAV gene delivery vectors -some of which are currently being tested in clinical trials- as well a variety of virologic assays and in vivo work to determine efficacy of vaccines.